Skip to main content
OpenTrials
Completed

NCT Number: NCT04759950

Exercise the Mind and Brain. A Multimodal Intervention in Stroke

The main objective of MindFit Project is to develop an evidence-based multimodal investigation of combined non-pharmacological strategies in chronic stroke patients and clarify the neuroplasticity mechanisms underlying the benefits of physical exercise and mindfulness strategies combined with cognitive training on post-stroke recovery. The investigators have adopted a multidisciplinary and multimodal approach to provide a more integrative perspective using cognitive, social-psychological, biochemical, and neuroimaging measurements.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stroke Behavior Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Motor Activity Nervous System Diseases Vascular Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Maria Mataro

Barcelona, Spain

About this study

The MindFit Project is a multicentric, prospective, parallel, single-blinded, randomized controlled trial with a sample of 141 participants at 3 to 60 months after stroke. Participants are randomly allocated to one of three arms (through a simple randomizing procedure with a 1:1:1 ratio created with a random sequence generator software).

The first group (n=47) receives computer-based cognitive training (CCT) combined with a multicomponent physical exercise program. The second group (n=47) receives CCT combined with mindfulness-based stress reduction therapy. Finally, the third group (n=47), as an active control group, receives only CCT. All interventions last 12 weeks.

Within two weeks before the start of the interventions, and again at 3 months after completing the interventions, medical, cognitive, and physical assessments, neuroimaging, and biological samples collection are performed.

The objectives of this project are:

  • To examine the effects of multimodal interventions in a population of chronic stroke patients on various domains: cognition, emotion, physical health, and quality of life.
  • To examine specific plasticity effects of each of the three interventions regarding structural and functional magnetic resonance imaging (MRI) and how these changes may contribute to cognitive and emotional benefits.
  • To study the molecular mechanisms by which the different types of interventions influence cognitive, emotional and brain benefits.
  • To study interventions-induced microbiome changes and to explain how these changes may induce inflammatory and immune responses that may contribute to cognitive, emotional and brain benefits.
  • To determine the demographic, clinical and genetic factors that may modulate cognitive, emotional and brain changes: baseline cognitive status; baseline cerebral status (atrophy, total intracranial volume); sex; age, educational level, intelligence.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals aged 18-80 years old
  • Ischemic or hemorrhagic stroke
  • Stroke diagnoses between 3-60 months ago
  • To have consent from a physician to engage in an exercise intervention
  • Fluency in Catalan or Spanish (I.e., able to understand and speak)
  • Accept to take part in the study and sign the informed consent according to the Declaration of Helsinki.

Exclusion criteria

  • Cognitive impairment (MMSE > 23)
  • Severe aphasia (item 9 of the NIHSS scale ≥ 2)
  • Severe sensory problems
  • Other neurological conditions apart from stroke
  • Severe pre-stroke psychiatric disorders (e.g., bipolar disorder, schizophrenia)
  • History of alcohol or other toxic abuse

Exclusion criteria

only for MRI examination:

  • Claustrophobia
  • Medical device (e.g., pacemaker implants, stents)
  • Other metal objects in the body

Treatment and study plan

Multicomponent Physical Activity Program

Behavioral

The proposed physical exercise intervention follows the American College of Sports Medicine (ACSM, 2017) and the American Stroke Association (Billinger et al., 2014) recommendations for stroke patients. The five weekly 45-minute sessions are divided into (1) three sessions guided and supervised telematically by a physical exercise specialist and a physiotherapist; (2) and two autonomous exercise sessions. The supervised sessions include exercises to work aerobic capacity, muscle strength and endurance, flexibility, agility, and balance. The intensity of these exercises is prescribed individually according to each participant's initial level and are gradually increased as the program progresses. Participants are encouraged to walk at a similar intensity on autonomous physical exercise days as performed in the guided sessions (moderate intensity), based on the Borg scale of perceived exertion (Borg, 1982).

mindfulness-based stress reduction program

Behavioral

This intervention follows an adaptation of the scheme and instructions of the official Mindfulness-Based Stress Reduction (MBSR) program designed by Jon Kabat-Zinn. It includes body scanning, sitting meditation, and gentle hatha yoga techniques. An accredited mindfulness instructor leads the 12-week online program, which comprises a presentation session, followed by eight intervention sessions (once a week, lasting 2.5 hours) and an intensive practice session interspersed between sessions six and seven. Apart from the supervised session, the therapist asks participants to carry out some independent practice daily.

Computerized cognitive training

Behavioral

An accredited neuropsychologist programs and supervises the computerized cognitive training through the Guttmann Neuropersonal Trainer (GNPT®) platform. The 12-week program consists of five sessions a week (45 minutes each) that include personalized activities planned to stimulate executive functioning, attention, processing speed, and memory.

Primary outcomes

  1. Change in immediate verbal attention after receiving treatment

    Time frame: 3 months (at baseline, 3 months from baseline)

    Forward Digit Span (WAIS III)

  2. Change in verbal digit working memory after receiving treatment

    Time frame: 3 months (at baseline, 3 months from baseline)

    Backward Digit Span (WAIS III)

  3. Change in verbal memory after receiving treatment

    Time frame: 3 months (at baseline, 3 months from baseline)

    Rey Auditory Learning Test

  4. Change in visual memory after receiving treatment

    Time frame: 3 months (at baseline, 3 months from baseline)

    Rey's Complex Figure Test

  5. Change in executive function, verbal fluency after receiving treatment

    Time frame: 3 months (at baseline, 3 months from baseline)

    Phonetic Fluency is measured using the Controlled Oral Word Association Test, spanish adaptation, and semantic fluency test using the category Animal

  6. Change in executive function, inhibition after receiving treatment

    Time frame: 3 months (at baseline, 3 months from baseline)

    Stroop Test

  7. Change in executive function, set-switching task after receiving treatment

    Time frame: 3 months (at baseline, 3 months from baseline)

    Trail Making Test

  8. Change in language, naming after receiving treatment

    Time frame: 3 months (at baseline, 3 months from baseline)

    Boston naming Test

Secondary outcomes

  1. Changes in psychological distress

    Time frame: 3 months (at baseline, 3 months from baseline)

    Clinical Outcomes in Routine Evaluation (CORE-OM)

  2. Changes in depression and anxiety

    Time frame: 3 months (at baseline, 3 months from baseline)

    Depression Anxiety Stress Scale (DASS-21)

  3. Changes in wellbeing

    Time frame: 3 months (at baseline, 3 months from baseline)

    Ryff Scales of Psychological Wellbeing.

  4. Changes in Mindfulness

    Time frame: 3 months (at baseline, 3 months from baseline)

    Mindful Attention Awareness Scale (MAAS)

  5. Changes in White matter integrity

    Time frame: 3 months (at baseline, 3 months from baseline)

    White matter integrity: tractography

  6. Changes in Resting-state connectivity

    Time frame: 3 months (at baseline, 3 months from baseline)

    Resting state brain activity using fMRI

  7. Changes in brain volumetry

    Time frame: 3 months (at baseline, 3 months from baseline)

    Grey and white matter volume measured by MRI

  8. Molecular changes: growth factors (BDNF, SDF1-a, VEGF-A, IGF-1, and NGF), cortisol, protein C reactive, IL-6 and homocysteine levels

    Time frame: 3 months (at baseline, 3 months from baseline)

    Quantification of different biomarkers from blood samples.

  9. Changes in Microbiota data

    Time frame: 3 months (at baseline, 3 months from baseline)

    Bacterial composition of stool samples in terms of relative abundance

  10. Changes in Sleep

    Time frame: 3 months (at baseline, 3 months from baseline)

    Pittsburgh Sleep Quality Index (PSQI)

  11. Changes in Fitness

    Time frame: 3 months (at baseline, 3 months from baseline)

    Senior Fitness Test (SFT)

  12. Changes in stroke specific quality of life

    Time frame: 3 months (at baseline, 3 months from baseline)

    Stroke-specific Quality of Life Scale (ECVI-38)

  13. Changes in quality of life

    Time frame: 3 months (at baseline, 3 months from baseline)

    World Health Organization Quality of Life (WHOQOL-BREF)

  14. Changes in mental fatigue

    Time frame: 3 months (at baseline, 3 months from baseline)

    Fatigue Assessment Scale (FAS)

  15. Changes in physical activity:

    Time frame: 3 months (at baseline, 3 months from baseline)

    Spanish version of the reduced Minnesota leisure-time physical and activity questionnaire (VREM)

Sponsors and collaborators

Lead sponsor

University of Barcelona

Other

Collaborators

  • Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
  • Fundació La Marató de TV3
  • Germans Trias i Pujol Hospital
  • Institut Guttmann
  • University of Pittsburgh

Registry information

Official study title

Effects of Combined Therapies of Physical Exercise, Mindfulness and Cognitive Stimulation on Cognition and Neuroplasticity in Chronic Stroke Patients: A Randomized Controlled Trial

Acronym: Mindfit

Important dates

Study start
2020
Primary completion
2021
Study completion
2022
First posted
Feb 18, 2021
Registry last updated
Mar 2, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.